NAD IV infusion
Selected indexed studies
- A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. (Front Aging Neurosci, 2019) [PMID:31572171]
- NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. (Ageing Res Rev, 2026) [PMID:41655607]
- Intravenous infusion of nicotinamide adenine dinucleotide (NAD(+)) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. (Front Aging, 2026) [PMID:41704678]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. (2019) pubmed
- NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. (2026) pubmed
- Intravenous infusion of nicotinamide adenine dinucleotide (NAD(+)) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. (2026) pubmed
- Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension. (2022) pubmed
- The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury. (2014) pubmed
- Influence of ethanol consumption and food intake on serum concentrations of endogenous steroids. (2024) pubmed
- Treatment of Parkinson's disease with NADH. (1994) pubmed
- Oxidative stress contributes to renovascular hypertension. (2008) pubmed
- Functional connectivity differences in the amygdala are related to the antidepressant efficacy of ketamine in patients with anxious depression. (2023) pubmed
- SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension. (2017) pubmed